Klinken S P, Billelo J, Bauer S, Morse H C, Thorgeirsson S S
Cancer Res. 1987 May 15;47(10):2638-44.
alpha-Difluoromethylornithine (DFMO) is an irreversible inhibitor of ornithine decarboxylase (ODC) and restricts the proliferation and differentiation of Friend murine erythroleukemia cells. We have studied the effect of this compound on the expression of ODC, transferrin receptor (TFR), and beta-globin during normal cellular proliferation and dimethylsulfoxide-induced terminal differentiation. Elevated RNA levels for ODC were observed during both normal Friend murine erythroleukemia cell division and replication associated with terminal differentiation, but these transcripts decreased as the cells ceased proliferating. However, in the presence of DFMO the levels of ODC remained elevated even when the cells had stopped dividing; this appears to be a feedback mechanism to overcome the effects of the inhibitor. TFR expression paralleled regular cell division and was curtailed when replication was reduced by DFMO. However, the inhibitor was unable to prevent the differentiation associated maintenance of TFR levels, well after proliferation terminated. While DFMO was able to restrict differentiation and hemoglobin synthesis, it did not inhibit the dimethylsulfoxide-induced expression of beta-globin RNA. We concluded that the block in differentiation caused by DFMO occurs along some pathway(s) other than the activation of beta-globin or TFR.
α-二氟甲基鸟氨酸(DFMO)是鸟氨酸脱羧酶(ODC)的不可逆抑制剂,可限制弗氏小鼠红白血病细胞的增殖和分化。我们研究了该化合物在正常细胞增殖以及二甲基亚砜诱导的终末分化过程中对ODC、转铁蛋白受体(TFR)和β-珠蛋白表达的影响。在正常弗氏小鼠红白血病细胞分裂以及与终末分化相关的复制过程中,均观察到ODC的RNA水平升高,但随着细胞停止增殖,这些转录本水平下降。然而,在存在DFMO的情况下,即使细胞停止分裂,ODC水平仍保持升高;这似乎是一种克服抑制剂作用的反馈机制。TFR的表达与正常细胞分裂平行,当DFMO减少复制时,其表达受到抑制。然而,在增殖终止后很长时间,该抑制剂仍无法阻止与分化相关的TFR水平维持。虽然DFMO能够限制分化和血红蛋白合成,但它并不抑制二甲基亚砜诱导的β-珠蛋白RNA表达。我们得出结论,DFMO引起的分化阻滞发生在除β-珠蛋白或TFR激活之外的某些途径上。